Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Phagocytosis and Immune Regulation, and Immunotherapy and Immune Responses.
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer